Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

Biologic Usage and Psoriasis Patients: What’s the barrier?

June 13, 2019

Many people living with psoriasis still do not use biologics, but those who do show greater HCP satisfaction and condition control.

David Shronk, Health Union’s SVP of Media, Recognized Among 2019 PM360 ELITE

May 16, 2019

PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech and medical device sectors, has named David Shronk, Health Union’s senior vice president of media, as one of the 2019 PM360 ELITE 100 in the Sales MVP category.

Redefining DTC Advertising: Capitalizing on a multi-dimensional, largely digital experience

April 30, 2019

The way people consume television - and advertising - is changing, quickly. When reaching people living with chronic health conditions, the complex and fragmented media landscape, along with fragmented attention spans, creates challenges for pharma marketers who are trying to drive awareness and interest in their brands.

Healthcare Industry Thought Leadership

Biologic Usage and Psoriasis Patients: What’s the barrier?

David Shronk, Health Union’s SVP of Media, Recognized Among 2019 PM360 ELITE

Redefining DTC Advertising: Capitalizing on a multi-dimensional, largely digital experience

FREE WEBINAR DOWNLOAD: Millennials and Health – 3 Ways Pharma Needs to Adapt to Attract

Psoriatic Arthritis Patient-Reported Data | 2020

Skin Cancer Patient-Reported Data | 2020

Q&A with Health Union co-founders Tim Armand & Olivier Chateau

Bladder Cancer Patient-Reported Data | 2020

Contact